Tag Archives: Parkinson’s

FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes

FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes Print this page SAN DIEGO – April 27, 2020 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Ongentys (opicapone) 25 mg and 50 mg capsules as an… Read More »

Medical News Today: Could a probiotic prevent or reverse Parkinson’s?

A new study using a roundworm model of Parkinson’s disease found that a probiotic bacterium could prevent, and in some cases reverse, toxic protein buildup. Misfolded alpha-synuclein proteins in the brain are the hallmark sign of Parkinson’s disease. Many experts believe that these toxic protein clumps lead to the progressive loss of brain cells that… Read More »

Study unravels new insights into a Parkinson’s disease protein

Research on alpha-synuclein highlights a potential therapeutic strategy By Charlotte Hsu BUFFALO, N.Y. — Research by University at Buffalo biologists is providing new insights into alpha-synuclein, a small acidic protein associated with Parkinson’s disease. Alpha-synuclein is known to form abnormal clumps in the brains of patients with Parkinson’s, but scientists are still trying to understand… Read More »